Join
Live feed
·
PRReleasevia Quantisnow
Stealth BioTherapeutics Corp. ADS logo

Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

ByQuantisnow·Wall Street's wire, on your screen.
MITO· Stealth BioTherapeutics Corp. ADS
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MITO (Stealth BioTherapeutics Corp. ADS) and more on Quantisnow.